Zoetis stock sinks 20% after earnings miss and guidance cut
Updated
Updated · Barron's · May 7
Zoetis stock sinks 20% after earnings miss and guidance cut
9 articles · Updated · Barron's · May 7
Shares fell to $88.94 on Thursday, the S&P 500's worst performance, putting them on track for their lowest close in more than seven years.
First-quarter earnings were $1.53 a share on $2.26 billion revenue, both below forecasts, as pet owners cut vet visits and demand for premium products weakened.
Zoetis lowered 2026 profit guidance to $6.85-$7.00 a share and revenue to $9.68-$9.96 billion; the stock is now down 29% this year.
Is Zoetis's premium drug strategy failing to adapt to a new generation of price-conscious pet owners?
As vet bills surge, is the dream of pet ownership becoming financially unsustainable for many?
Can AI and virtual care disrupt the vet industry and solve the affordability crisis for pet owners?